Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00501085 · ClinicalTrials.gov registry record
LAP-BAND AP Early Experience Trial (APEX)
A clinical trial, sponsored by Apollo Endosurgery.
- Completed
- Registry status
- 521
- Enrollment target
NCT00501085: Completed study, sponsored by Apollo Endosurgery.
NCT00501085 is a clinical trial that has completed, run by Apollo Endosurgery. The registered enrollment target is 521 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00501085 has completed, sponsored by Apollo Endosurgery.
- COMPLETED
- Registry status
- 521 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the LAP-BAND AP System in severely obese patients.
Primary Outcome
Subjects' Percent Excess Weight Loss (%EWL) from baseline over the 5 year period post LAP-BAND implantation was measured. Excess Weight = Baseline weight - Ideal weight, where ideal weight is based on a BMI of 25 kg/m2.
Interventions
- DEVICE LAP-BAND AP Adjustable Gastric Banding System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 521 participants |
| Start Date | 2007-06 |
| Est. Completion | 2013-11 |
What the finished NCT00501085 record still lists
NCT00501085 is an observational study that tracks outcomes without assigning an intervention. The registered 521 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which LAP-BAND AP Adjustable Gastric Banding System is the first listed.
NCT00501085 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00501085 about?
NCT00501085 is a clinical study titled "LAP-BAND AP Early Experience Trial (APEX)". The purpose of this study is to evaluate the LAP-BAND AP System in severely obese patients.
What is the current status of trial NCT00501085?
This trial is currently completed. The enrollment target is 521 participants. The study started on 2007-06. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00501085?
The interventions under investigation include: LAP-BAND AP Adjustable Gastric Banding System (DEVICE).
Who is sponsoring clinical trial NCT00501085?
This trial is sponsored by Apollo Endosurgery, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06835686 · 522 participants · NA
Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial
- NCT06894212 · 522 participants · Phase 3
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
- NCT02323581 · 520 participants · NA
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
- NCT04656496 · 520 participants · NA
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia